Quick Answer
ENvue Medical, Inc. reported Diluted EPS of $13.73 per share (loss) for fiscal year 2024.
ENvue Medical, Inc. Diluted EPS — Annual History
| Fiscal Year | Diluted EPS | YoY Change |
|---|---|---|
| 2024 | -$13.73 | +41.1% |
| 2023 | -$23.32 | -507.3% |
| 2022 | -$3.84 | — |
Quarterly Diluted EPS
| Quarter Ending | Diluted EPS | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$0.91 | +74.4% | +11.7% |
| June 30, 2025 | -$1.03 | +96.2% | -125.9% |
| March 31, 2025 | $3.98 | +67.2% | +211.8% |
| September 30, 2024 | -$3.56 | -747.6% | +86.9% |
| June 30, 2024 | -$27.18 | -4081.5% | -1242.0% |
| March 31, 2024 | $2.38 | +455.2% | +666.7% |
| September 30, 2023 | -$0.42 | +38.2% | +35.4% |
| June 30, 2023 | -$0.65 | +30.1% | +3.0% |
- ENvue Medical, Inc. showed an increase of +41.1% in Diluted EPS compared to the prior fiscal year.
- Over the 2022–2024 period, ENvue Medical, Inc.’s diluted eps has declined by 257.6% (from $3.84 per share (loss) to $13.73 per share (loss)).
- The most recent figure is from ENvue Medical, Inc.’s fiscal year 2024 report (Form 10-K), filed with the SEC on March 31, 2025.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: